A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs.
Benjamin Andreas BerkTsz H LawRowena M A PackerAnnette WessmannAndrea Bathen-NöthenTarja S JokinenAnna KnebelAndrea TipoldLudovic PelligandZoe MeadsHolger A VolkPublished in: Journal of veterinary internal medicine (2020)
These data show antiseizure properties of an MCT-DS compared to a control oil and support former evidence for the efficacy of MCTs as a nutritive, management option for a subpopulation of drug-resistant dogs with epilepsy.